Investigative Reporting

Purdue Pharma’s Settlement: A Partial Win Amid Deep Accountability Questions

By Economics Desk | November 15, 2025

The proposed Purdue Pharma settlement promises billions for opioid victims but raises tough questions about real accountability and the Sackler family’s role in America’s crisis.

On the surface, the recent judge-approved settlement for Purdue Pharma may appear as a step toward justice for thousands of Americans devastated by opioids. But beneath this veneer lies a complex narrative that challenges the core principles of accountability, sovereignty, and protecting American families from corporate greed.Is This Just Another Corporate Bailout Disguised as Justice?At its heart, Purdue Pharma, owned by the Sackler family, has been at the center of America's opioid epidemic—a crisis responsible for nearly a million deaths since 1999. While other companies also sold opioids, it was the aggressive and irresponsible marketing of OxyContin starting in 1996...

This is Exclusive Content for Subscribers

Join our community of patriots to read the full story and get access to all our exclusive analysis.

View Subscription Plans